| Dr Dionne M Payne, PHARMD | |
|
19340 Hawthorne Blvd, Torrance, CA 90503-1506 | |
| (310) 750-2357 | |
| Not Available |
| Full Name | Dr Dionne M Payne |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 19340 Hawthorne Blvd, Torrance, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922330125 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 60997 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dionne M Payne, PHARMD 3500 W Manchester Blvd Unit 173, Inglewood, CA 90305-4173 Ph: (323) 490-8116 | Dr Dionne M Payne, PHARMD 19340 Hawthorne Blvd, Torrance, CA 90503-1506 Ph: (310) 750-2357 |
News Archive
The patient-centered medical home model of healthcare includes principles of medical ethics and professionalism that could reinvigorate the patient‑physician relationship and enhance the ethical practice of medicine, suggest members of the American College of Physicians.
Australian researchers have made a world-first breakthrough in the early detection of patients' resistance to a common treatment for chronic myeloid leukemia.
BlueWind Medical, developer of a wireless neuro-stimulation device to treat multiple clinical indications, such as back pain, peripheral neuropathic pain, incontinence (OAB), epilepsy, and more, announced today the completion of patient enrolment for an Overactive Bladder (OAB) study which is currently being conducted to support CE Mark submission.
Viamet Pharmaceuticals, Inc. announced today that one of its novel antifungal compounds has been selected for inclusion in the National Institutes of Health's (NIH) Therapeutics for Rare and Neglected Diseases (TRND) program.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that data provided in a presentation entitled, "Antitumor activity of single small molecule agent targeting PI3K/mTor and HDAC," were presented at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010, which is being held in Washington, DC April 17-21.
› Verified 8 days ago
Dr. Helen Haekyong Whang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3860 Sepulveda Blvd, Torrance, CA 90505 Phone: 310-373-5884 Fax: 310-373-9263 | |
Flora Amy Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4101 Torrance Blvd, Torrance, CA 90503 Phone: 310-540-7676 | |
Christine Gobran, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 Lomita Blvd, Torrance, CA 90505 Phone: 310-784-8713 | |
Dr. Ahmed Sadek Atallah, PHD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1327 El Prado Ave, Torrance, CA 90501 Phone: 310-328-7244 Fax: 310-782-3519 | |
Young Yoon Sung, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2800 Plaza Del Amo Unit 14, #14, Torrance, CA 90503 Phone: 310-619-4269 | |
Kristin Anne Dionisio Ignacio, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3640 Lomita Blvd Ste 106, Torrance, CA 90505 Phone: 310-784-8713 | |
Gordana Cutovic, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23600 Telo Ave Ste 150, Torrance, CA 90505 Phone: 424-250-1701 |